Daniel Camardo

Direttore/Membro del Consiglio presso CommunityHealth NFP

Patrimonio netto: 1 712 $ in data 31/05/2024

55 anni

Health Technology

Consumer Services

Posizioni attive di Daniel Camardo

Società	Posizione	Inizio	Fine
CommunityHealth NFP	Direttore/Membro del Consiglio	-	-

Società	Posizione	Inizio	Fine
ATHERSYS, INC.	Comptroller/Controller/Auditor	02/07/2022	31/12/2023
	Direttore/Membro del Consiglio	14/02/2022	31/12/2023
	Amministratore Delegato	14/02/2022	31/12/2023
	Direttore Finanziario/CFO	02/07/2022	-
	Segretario Aziendale	14/02/2022	31/12/2023
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY	Corporate Officer/Principal	01/09/2015	01/02/2022
Clarus Therapeutics, Inc. Clarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Clarus Therapeutics, Inc. operated as a men's health specialty pharmaceutical company that focuses on the development and commercialization of oral testosterone replacement therapy. It offered JATENZO, a soft gel oral formulation of testosterone undecanoate for treating hypogonadal men. The company was founded by Robert E. Dudley in February 2004 and was headquartered in Northbrook, IL.	Vendite & Marketing	01/07/2014	01/09/2015
Astellas Pharma US, Inc. Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma US, Inc. manufactures pharmaceutical products. It offers cardiology, dermatology, immunology, infectious diseases, and urology. The firm was founded in 2005 and is headquartered in Northbrook, IL.	Corporate Officer/Principal	01/01/2003	01/01/2004

Rochester Christian University	Undergraduate Degree
Kellogg School of Management	Masters Business Admin

Distribuzione geografica

Stati Uniti	7
Irlanda	2

Posizioni

Corporate Officer/Principal	2
Director/Board Member	2
Comptroller/Controller/Auditor	1

Settori

Health Technology	5
Consumer Services	3

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	1
ATHERSYS, INC.	Health Technology

Aziende private	4
Horizon Therapeutics Plc Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland.	Health Technology
Clarus Therapeutics, Inc. Clarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Clarus Therapeutics, Inc. operated as a men's health specialty pharmaceutical company that focuses on the development and commercialization of oral testosterone replacement therapy. It offered JATENZO, a soft gel oral formulation of testosterone undecanoate for treating hypogonadal men. The company was founded by Robert E. Dudley in February 2004 and was headquartered in Northbrook, IL.	Health Technology
Astellas Pharma US, Inc. Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma US, Inc. manufactures pharmaceutical products. It offers cardiology, dermatology, immunology, infectious diseases, and urology. The firm was founded in 2005 and is headquartered in Northbrook, IL.	Health Technology
CommunityHealth NFP